Hotchkis & Wiley Capital Management
NUS icon

Hotchkis & Wiley Capital Management’s Nu Skin NUS Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,575,505
Closed -$10.9M – 497
2024
Q4 		$10.9M Buy
1,575,505
+971,950
+161% +$6.68M 0.04% 233
2024
Q3 		$4.45M Buy
603,555
+130,980
+28% +$1.22M 0.01% 404
2024
Q2 		$4.98M Buy
472,575
+34,750
+8% +$440K 0.02% 393
2024
Q1 		$6.06M Buy
437,825
+137,580
+46% +$2.15M 0.02% 354
2023
Q4 		$5.83M Buy
300,245
+71,790
+31% +$1.32M 0.02% 384
2023
Q3 		$4.85M Buy
228,455
+28,510
+14% +$741K 0.02% 395
2023
Q2 		$6.64M Buy
199,945
+47,280
+31% +$1.74M 0.02% 325
2023
Q1 		$6M Buy
152,665
+18,520
+14% +$770K 0.02% 324
2022
Q4 		$5.66M Buy
134,145
+21,840
+19% +$840K 0.02% 324
2022
Q3 		$3.75M Buy
112,305
+350
+0.3% +$14.6K 0.02% 384
2022
Q2 		$4.85M Buy
111,955
+4,025
+4% +$185K 0.02% 335
2022
Q1 		$5.17M Buy
107,930
+5,770
+6% +$286K 0.02% 345
2021
Q4 		$5.18M Buy
102,160
+3,980
+4% +$177K 0.02% 321
2021
Q3 		$3.97M Buy
98,180
+10,400
+12% +$526K 0.01% 392
2021
Q2 		$4.97M Buy
87,780
+9,170
+12% +$522K 0.02% 319
2021
Q1 		$4.16M Buy
78,610
+10,600
+16% +$577K 0.01% 358
2020
Q4 		$3.71M Sell
68,010
-35,880
-35% -$1.89M 0.01% 311
2020
Q3 		$5.2M Sell
103,890
-24,430
-19% -$1.16M 0.02% 141
2020
Q2 		$4.91M Sell
128,320
-63,160
-33% -$2.03M 0.02% 169
2020
Q1 		$4.18M Buy
191,480
+13,040
+7% +$392K 0.02% 192
2019
Q4 		$7.31M Buy
178,440
+35,670
+25% +$1.46M 0.03% 166
2019
Q3 		$6.07M Buy
142,770
+26,980
+23% +$1.13M 0.02% 147
2019
Q2 		$5.71M Buy
+115,790
New +$5.89M 0.02% 178
2018
Q2 		– Sell
-12,705
Closed -$936K – 515
2018
Q1 		$936K Hold
12,705
– – ﹤0.01% 327
2017
Q4 		$867K Buy
+12,705
New +$822K ﹤0.01% 333

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Hotchkis & Wiley Capital Management's NUS Position: Q1 2025 in Review

Hotchkis & Wiley Capital Management sold out of Nu Skin (NUS) in Q1 2025, closing a stake of 1,575,505 shares — an estimated $10.9M sold.

Hotchkis & Wiley Capital Management first reported a position in NUS in Q4 2017 and held it in 25 quarters. The position peaked at $10.9M in Q4 2024. 195 funds tracked by Wall St. Rank hold NUS as of Q1 2025.

  • Hotchkis & Wiley Capital Management reported no remaining Nu Skin position as of Q1 2025 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 1,575,505 Nu Skin shares in Q1 2025, an estimated $10.9M.
  • Hotchkis & Wiley Capital Management first reported a position in Nu Skin in Q4 2017 and held it in 25 quarters.
  • Hotchkis & Wiley Capital Management's Nu Skin position peaked at $10.9M in Q4 2024.
  • 195 funds tracked by Wall St. Rank held Nu Skin as of Q1 2025.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2025, filed 14 May 2025.